5MinuteHematology

Teclistamab + Daratumumab (MajesTEC-3) Protocol

Curated Five Minute Hematology reference for Teclistamab + Daratumumab (MajesTEC-3). Open the approved protocol in 5MH Tools.

Targeted Therapy Treatment regimen

Open protocol

Continue to the reviewed 5MH Tools protocol reference for regimen details, schedule, supportive-care context, evidence and source transparency.

Open protocol All 5MH Tools
Protocol reference Teclistamab + Daratumumab (MajesTEC-3) · Targeted Therapy · Treatment regimen · v1.2.1
Aliases Tec-Dara, MajesTEC-3, MajesTEC-3 Tec-Dara
Medical review Reviewed 2026-10-07 · Step-up in week 1 → weekly through week 8 → every 2 weeks through week 24 → every 4 weeks from week 25; continue until progression or unacceptable toxicity
Protocol type Defined multi-drug regimen with a specified treatment schedule.
Source transparency Evidence references are available in the approved 5MH protocol.
For qualified healthcare professionals · Educational and professional reference use only · Verify clinically relevant information against original sources